Business & Consumer Services » Shell companies | Profound Medical Corp.

Profound Medical Corp. | Ownership

Companies that own Profound Medical Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity (Canada) Asset Management ULC
6,200,000
5.74%
25,000
0.01%
07/31/2018
Gagnon Securities LLC
4,002,090
3.7%
585,958
0.72%
06/30/2018
Gagnon Advisors LLC
1,826,925
1.69%
478,073
0.73%
06/30/2018
Galileo Global Equity Advisors, Inc.
400,000
0.37%
400,000
0.77%
06/30/2018
Purpose Investments, Inc.
300,000
0.28%
0
0.02%
06/29/2018
Arrow Capital Management, Inc.
187,400
0.17%
187,400
0.07%
06/30/2018

About Profound Medical

View Profile
Address
2400 Skymark Avenue
Mississauga Ontario L4W 5K5
Canada
Employees -
Website http://www.profoundmedical.com
Updated 07/08/2019
Profound Medical Corp. engages in developing and commercializing minimally invasive treatments for prostate cancer. It develops Transurethral Ultrasound Ablation-PRO system that completed a Phase I clinical trial, which combines magnetic resonance imaging guidance, and ultrasound energy to deliver thermal ablative therapy to the prostate gland delivered through the urethra. Profound Medical was founded in 2008 and is headquartered in Toronto, CA.